The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Morphology of sporadic colorectal cancer with DNA replication errors
Open accessAbstract
Background —Up to 15% of colorectal cancers are characterised by DNA microsatellite instability (MIN), shown by the presence of DNA replication errors (RERs). Aims —To identify pathological features that are discriminating for colorectal cancer (CRC) showing extensive MIN. Subjects —A prospective series of 303 patients with CRC and no family history of either familial adenomatous polyposis or hereditary non-polyposis colorectal cancer. Methods —DNA was extracted from fresh tissue samples and the presence of MIN was studied at nine loci that included TGFβRII, IGFIIR, and BAX. The 61 cases showing RERs were compared with 63 RER negative cases with respect to a comprehensive set of clinical and pathological variables. Predictive utility of the variables was tested by decision tree analysis. Results —Twenty seven patients with CRC showed extensive RERs (three loci or more) (RER+) and 34 had limited RERs only (28 = one locus; 6 = two loci) (RER+/−), yielding a bimodal distribution. RER+ cancers differed from RER− and RER+/− cases. Tumour type (adenocarcinoma, mucinous carcinoma, and undifferentiated carcinoma) (p=0.001), tumour infiltrating lymphocytes (p=0.001), and anatomical site (p=0.001) were the most significant of the discriminating variables. Algorithms developed by decision tree analysis allowed cases to be assigned to RER+ versus RER− and +/− status with a global sensitivity of 81.5%, specificity of 96%, and overall accuracy of 93%. Conclusion —Pathological examination of CRC allows assignment of RER+ status; assignment is specific and relatively sensitive. Conversely RER− and RER+/− CRC are indistinguishable.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Classification and Regression Trees.
Gordon, A. D., Breiman, L., Friedman, J. H., Olshen, R. A., & Stone, C. J. (1984) · Biometrics · doi:10.2307/2530946 · Cited by 23,522
Classification and Regression Trees.
Ryzin, J. V., Breiman, L., Friedman, J. H., Olshen, R. A., & Stone, C. J. (1986) · Journal of the American Statistical Association · doi:10.2307/2288003 · Cited by 20,825
Classification And Regression Trees
Breiman, L., Friedman, J. H., Olshen, R. A., & Stone, C. J. (2017) · doi:10.1201/9781315139470 · Cited by 11,417
Microsatellite Instability in Cancer of the Proximal Colon
Thibodeau, S. N., Bren, G., & Schaid, D. (1993) · Science · doi:10.1126/science.8484122 · Cited by 3,130
The human mutator gene homolog MSH2 and its association with hereditary nonpolyposis colon cancer
Fishel, R., Lescoe, M. K., Rao, M. R. S., Copeland, N. G., Jenkins, N. A., Garber, J., Kane, M., & Kolodner, R. (1993) · Cell · doi:10.1016/0092-8674(93)90546-3 · Cited by 2,873
Clues to the Pathogenesis of Familial Colorectal Cancer
Aaltonen, L. A., Peltomäki, P., Leach, F. S., Sistonen, P., Pylkkänen, L., Mecklin, J.-P., Järvinen, H., Powell, S. M., Jen, J., Hamilton, S. R., et al. (1993) · Science · doi:10.1126/science.8484121 · Cited by 2,710
Ionov, Y., Peinado, M. A., Malkhosyan, S., Shibata, D., & Perucho, M. (1993) · Nature · doi:10.1038/363558a0 · Cited by 2,708
Mutations of a mutS homolog in hereditary nonpolyposis colorectal cancer
Leach, F. S., Nicolaides, N. C., Papadopoulos, N., Liu, B., Jen, J., Parsons, R., Peltomäki, P., Sistonen, P., Aaltonen, L. A., Nyström-Lahti, M., et al. (1993) · Cell · doi:10.1016/0092-8674(93)90330-s · Cited by 2,276
Self-citationInactivation of the Type II TGF-β Receptor in Colon Cancer Cells with Microsatellite Instability
Markowitz, S., Wang, J., Myeroff, L., Parsons, R., Sun, L., Lutterbaugh, J., Fan, R. S., Zborowska, E., Kinzler, K. W., Vogelstein, B., et al. (1995) · Science · doi:10.1126/science.7761852 · Cited by 2,270
Bronner, C. E., Baker, S. M., Morrison, P. T., Warren, G., Smith, L. G., Lescoe, M. K., Kane, M., Earabino, C., Lipford, J., Lindblom, A., et al. (1994) · Nature · doi:10.1038/368258a0 · Cited by 2,052
Cited by
Lynch, H. T., & de la Chapelle, A. (2003) · New England Journal of Medicine · doi:10.1056/nejmra012242 · Cited by 2,203
Immunotherapy in colorectal cancer: Rationale, challenges and potential
Ganesh, K., Stadler, Z. K., Cercek, A., Mendelsohn, R. B., Shia, J., Segal, N. H., & Diaz, L. A. (2019) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-019-0126-x · Cited by 1,954
Landon, M., Saam, J., Brown, K. L., Moyes, K., Evans, B., & Wenstrup, R. (2015) · Oncology · doi:10.1159/000430097 · Cited by 1,939
Jass, J. R. (2007) · Histopathology · doi:10.1111/j.1365-2559.2006.02549.x · Cited by 1,384
Self-citationPrognostic Factors in Prostate Cancer: College of American Pathologists Consensus Statement 1999
Bostwick, D. G., Grignon, D. J., Hammond, M. E. H., Amin, M. B., Cohen, M., Crawford, D., Gospadarowicz, M., Kaplan, R. S., Miller, D. S., Montironi, R., et al. (2000) · Archives of Pathology & Laboratory Medicine · doi:10.5858/2000-124-0995-pfipc · Cited by 1,239
Prognostic Factors in Colorectal Cancer: College of American Pathologists Consensus Statement 1999
Compton, C. C., Fielding, L. P., Burgart, L. J., Conley, B., Cooper, H. S., Hamilton, S. R., Hammond, M. E. H., Henson, D. E., Hutter, R. V. P., Nagle, R. B., et al. (2000) · Archives of Pathology & Laboratory Medicine · doi:10.5858/2000-124-0979-pficc · Cited by 1,230
Role of the Serrated Pathway in Colorectal Cancer Pathogenesis
Leggett, B., & Whitehall, V. (2010) · Gastroenterology · doi:10.1053/j.gastro.2009.12.066 · Cited by 977
Self-citationGenomic Correlates of Immune-Cell Infiltrates in Colorectal Carcinoma
Giannakis, M., Mu, X. J., Shukla, S. A., Qian, Z. R., Cohen, O., Nishihara, R., Bahl, S., Cao, Y., Amin-Mansour, A., Yamauchi, M., et al. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.03.075 · Cited by 913
Lynch, H., Lynch, P., Lanspa, S., Snyder, C., Lynch, J., & Boland, C. (2009) · Clinical Genetics · doi:10.1111/j.1399-0004.2009.01230.x · Cited by 840
Immunohistochemistry Versus Microsatellite Instability Testing in Phenotyping Colorectal Tumors
Lindor, N. M., Burgart, L. J., Leontovich, O. N., Goldberg, R. M., Cunningham, J. M., Sargent, D. J., Walsh-Vockley, C., Petersen, G. M., Walsh, M. D., Leggett, B., et al. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.20.4.1043 · Cited by 817
Self-citationVenderbosch, S., Nagtegaal, I. D., Maughan, T. S., Smith, C. G., Cheadle, J. P., Fisher, D., Kaplan, R., Quirke, P., Seymour, M. T., Richman, S. D., et al. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-0332 · Cited by 772
The colorectal adenoma–carcinoma sequence
Leslie, A., Carey, F. A., Pratt, N. R., & Steele, R. J. C. (2002) · British Journal of Surgery · doi:10.1046/j.1365-2168.2002.02120.x · Cited by 734
BRAF mutation is associated with DNA methylation in serrated polyps and cancers of the colorectum
Kambara, T., Simms, L. A., Whitehall, V. L. J., Spring, K. J., Wynter, C. V. A., Walsh, M. D., Barker, M. A., Arnold, S., McGivern, A., Matsubara, N., et al. (2004) · Gut · doi:10.1136/gut.2003.037671 · Cited by 722
Self-citationAmerican Joint Committee on Cancer prognostic factors consensus conference: Colorectal working group
Compton, C., Fenoglio-Preiser, C. M., Pettigrew, N., & Fielding, L. P. (2000) · Cancer · doi:10.1002/(sici)1097-0142(20000401)88:7<1739::aid-cncr30>3.0.co;2-t · Cited by 599
Elsaleh, H., Joseph, D., Grieu, F., Zeps, N., Spry, N., & Iacopetta, B. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02261-3 · Cited by 552
Sinicrope, F. A., Foster, N. R., Thibodeau, S. N., Marsoni, S., Monges, G., Labianca, R., Yothers, G., Allegra, C., Moore, M. J., Gallinger, S., et al. (2011) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djr153 · Cited by 543
SIGNALING PATHWAYS IN INTESTINAL DEVELOPMENT AND CANCER
Sancho, E., Batlle, E., & Clevers, H. (2004) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.20.010403.092805 · Cited by 532
Tumor-infiltrating lymphocytes are a marker for microsatellite instability in colorectal carcinoma
Smyrk, T. C., Watson, P., Kaul, K., & Lynch, H. T. (2001) · Cancer · doi:10.1002/1097-0142(20010615)91:12<2417::aid-cncr1276>3.0.co;2-u · Cited by 522
Histopathological Identification of Colon Cancer with Microsatellite Instability
Alexander, J., Watanabe, T., Wu, T.-T., Rashid, A., Li, S., & Hamilton, S. R. (2001) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63994-6 · Cited by 511
The serrated pathway to colorectal carcinoma: current concepts and challenges
Bettington, M., Walker, N., Clouston, A., Brown, I., Leggett, B., & Whitehall, V. (2013) · Histopathology · doi:10.1111/his.12055 · Cited by 502
Self-citationPathology of mouse models of intestinal cancer: Consensus report and recommendations
Boivin, G. P., Washington, K., Yang, K., Ward, J. M., Pretlow, T. P., Russell, R., Besselsen, D. G., Godfrey, V. L., Doetschman, T., Dove, W. F., et al. (2003) · Gastroenterology · doi:10.1053/gast.2003.50094 · Cited by 496
Emerging concepts in colorectal neoplasia
Jass, J. R., Whitehall, V. L. J., Young, J., & Leggett, B. A. (2002) · Gastroenterology · doi:10.1053/gast.2002.35392 · Cited by 495
Self-citationDolcetti, R., Viel, A., Doglioni, C., Russo, A., Guidoboni, M., Capozzi, E., Vecchiato, N., Macrì, E., Fornasarig, M., & Boiocchi, M. (1999) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65436-3 · Cited by 480
Use of 5-fluorouracil and survival in patients with microsatellite-unstable colorectal cancer
Carethers, J. M., Smith, E. J., Behling, C. A., Nguyen, L., Tajima, A., Doctolero, R. T., Cabrera, B. L., Goel, A., Arnold, C. A., Miyai, K., et al. (2004) · Gastroenterology · doi:10.1053/j.gastro.2003.12.023 · Cited by 471
Ogino, S., Nosho, K., Irahara, N., Meyerhardt, J. A., Baba, Y., Shima, K., Glickman, J. N., Ferrone, C. R., Mino-Kenudson, M., Tanaka, N., et al. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-1438 · Cited by 418
Colorectal Carcinoma: Diagnostic, Prognostic, and Molecular Features
Compton, C. C. (2003) · Modern Pathology · doi:10.1097/01.mp.0000062859.46942.93 · Cited by 403
Microsatellite instability and the clinicopathological features of sporadic colorectal cancer
Ward, R., Meagher, A., Tomlinson, I., O'Connor, T., Norrie, M., Wu, R., & Hawkins, N. (2001) · Gut · doi:10.1136/gut.48.6.821 · Cited by 384
Jenkins, M. A., Hayashi, S., O’Shea, A.-M., Burgart, L. J., Smyrk, T. C., Shimizu, D., Waring, P. M., Ruszkiewicz, A. R., Pollett, A. F., Redston, M., et al. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.04.044 · Cited by 373
Self-citationHawkins, N., Norrie, M., Cheong, K., Mokany, E., Ku, S., Meagher, A., O'Connor, T., & Ward, R. (2002) · Gastroenterology · doi:10.1053/gast.2002.32997 · Cited by 366
Bertagnolli, M. M., Niedzwiecki, D., Compton, C. C., Hahn, H. P., Hall, M., Damas, B., Jewell, S. D., Mayer, R. J., Goldberg, R. M., Saltz, L. B., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.18.2071 · Cited by 364
Young, J., Simms, L. A., Biden, K. G., Wynter, C., Whitehall, V., Karamatic, R., George, J., Goldblatt, J., Walpole, I., Robin, S.-A., et al. (2001) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63062-3 · Cited by 358
Self-citationHawkins, N. J., & Ward, R. L. (2001) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/93.17.1307 · Cited by 334
Zlobec, I., & Lugli, A. (2010) · Oncotarget · doi:10.18632/oncotarget.199 · Cited by 331
Molecular Markers Identify Subtypes of Stage III Colon Cancer Associated With Patient Outcomes
Sinicrope, F. A., Shi, Q., Smyrk, T. C., Thibodeau, S. N., Dienstmann, R., Guinney, J., Bot, B. M., Tejpar, S., Delorenzi, M., Goldberg, R. M., et al. (2015) · Gastroenterology · doi:10.1053/j.gastro.2014.09.041 · Cited by 330
Sinicrope, F. A., Rego, R. L., Ansell, S. M., Knutson, K. L., Foster, N. R., & Sargent, D. J. (2009) · Gastroenterology · doi:10.1053/j.gastro.2009.06.053 · Cited by 329
Guidoboni, M., Gafà, R., Viel, A., Doglioni, C., Russo, A., Santini, A., Del Tin, L., Macrì, E., Lanza, G., Boiocchi, M., et al. (2001) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)61695-1 · Cited by 322
“tumors with high-frequency MSI (MSI-H), both hereditary nonpolyposis colorectal cancer-related and sporadic, are characterized by preferential location in the proximal colon, diploid nuclear DNA content, high prevalence of mucinous and medullary histotypes, and poor differentiation.(12,13) Moreover, recent studies rep…”
BackgroundBiomarker-guided therapy for colorectal cancer: strength in complexity
Sveen, A., Kopetz, S., & Lothe, R. A. (2020) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-019-0241-1 · Cited by 320
Colorectal serrated adenocarcinoma
Mäkinen, M. J. (2007) · Histopathology · doi:10.1111/j.1365-2559.2006.02548.x · Cited by 316
Sinicrope, F. A., & Sargent, D. J. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-1469 · Cited by 309
Pathologic Predictors of Microsatellite Instability in Colorectal Cancer
Greenson, J. K., Huang, S.-C., Herron, C., Moreno, V., Bonner, J. D., Tomsho, L. P., Ben-Izhak, O., Cohen, H. I., Trougouboff, P., Bejhar, J., et al. (2009) · American Journal of Surgical Pathology · doi:10.1097/pas.0b013e31817ec2b1 · Cited by 286
“Nevertheless our results suggest that the current definition of mucinous carcinoma (requiring at least 50% of the tumor to be mucinous) may not be biologically relevant in the era of molecular testing.(11,23) The most accurate model of predicting MSI employed the log of the number of TIL/HPF.”
ResultmRNA/microRNA gene expression profile in microsatellite unstable colorectal cancer
Lanza, G., Ferracin, M., Gafà, R., Veronese, A., Spizzo, R., Pichiorri, F., Liu, C.-G., Calin, G. A., Croce, C. M., & Negrini, M. (2007) · Molecular Cancer · doi:10.1186/1476-4598-6-54 · Cited by 285
Hyperplastic-like Colon Polyps That Preceded Microsatellite-Unstable Adenocarcinomas
Goldstein, M., Bhanot, M., Odish, H., & Hunter, S. (2003) · American Journal of Clinical Pathology · doi:10.1309/drfq-0wfu-f1g1-3ctk · Cited by 283
Prognostic and predictive factors in colorectal cancer
Zlobec, I., & Lugli, A. (2008) · Postgraduate Medical Journal · doi:10.1136/jcp.2007.054858 · Cited by 280
Sinicrope, F. A., Mahoney, M. R., Smyrk, T. C., Thibodeau, S. N., Warren, R. S., Bertagnolli, M. M., Nelson, G. D., Goldberg, R. M., Sargent, D. J., & Alberts, S. R. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2013.48.9591 · Cited by 279
Development of a Fluorescent Multiplex Assay for Detection of MSI‐High Tumors
Bacher, J. W., Flanagan, L. A., Smalley, R. L., Nassif, N. A., Burgart, L. J., Halberg, R. B., Megid, W. M. A., & Thibodeau, S. N. (2004) · Disease Markers · doi:10.1155/2004/136734 · Cited by 276
American Joint Committee on Cancer Prognostic Factors Consensus Conference
Yarbro, J. W., Page, D. L., Fielding, L. P., Partridge, E. E., & Murphy, G. P. (1999) · Cancer · doi:10.1002/(sici)1097-0142(19991201)86:11<2436::aid-cncr35>3.0.co;2-# · Cited by 266
Genetic pathways in colorectal and other cancers
Ilyas, M., Straub, J., Tomlinson, I. P. M., & Bodmer, W. F. (1999) · European Journal of Cancer · doi:10.1016/s0959-8049(98)00431-6 · Cited by 257
Greenson, J. K., Bonner, J. D., Ben-Yzhak, O., Cohen, H. I., Miselevich, I., Resnick, M. B., Trougouboff, P., Tomsho, L. D., Kim, E., Low, M., et al. (2003) · The American Journal of Surgical Pathology · doi:10.1097/00000478-200305000-00001 · Cited by 252
Combined Mutation of Apc, Kras , and Tgfbr2 Effectively Drives Metastasis of Intestinal Cancer
Sakai, E., Nakayama, M., Oshima, H., Kouyama, Y., Niida, A., Fujii, S., Ochiai, A., Nakayama, K. I., Mimori, K., Suzuki, Y., et al. (2018) · Cancer Research · doi:10.1158/0008-5472.can-17-3303 · Cited by 133
Calin, G. A., Gafà, R., Tibiletti, M. G., Herlea, V., Becheanu, G., Cavazzini, L., Barbanti‐Brodano, G., Nenci, I., Negrini, M., & Lanza, G. (2000) · International Journal of Cancer · doi:10.1002/1097-0215(20000520)89:3<230::aid-ijc4>3.0.co;2-j · Cited by 103
Metadata
- Authors
- Jass, J. R., Do, K.-A., Simms, L. A., Iino, H., Wynter, C., Pillay, S. P., Searle, J., Radford-Smith, G., Young, J., & Leggett, B.
- Venue
- Gut
- Publisher
- BMJ
- Published
- 1998-05-01
- Volume
- 42
- Issue
- 5
- Pages
- 673-679
- ISSN
- 0017-5749 (ISSN-L)
- 1468-3288
- OpenAlex
- W2124841274
- Cited by
- 466
- References
- 34
- FWCI
- 21.59
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.